Диссертация (1146688), страница 27
Текст из файла (страница 27)
Marsh, J. Hinde // Gastroenterology. – 1985. –Vol. 89 (1). – P. 92–101.278. Mass screening for celiac disease using antihuman transglutaminase antibody assay / A. Tommassini [et al.] // Archives of disease in childhood. 2004. No. 89, Issue 6.P. 512515.279. May-Ling Tjon, J. Celiac disease: how complicated can it get? / Jeroen vanBergen, Frits Koning // Immunogenetics.
– 2010. – Vol. 62. – P. 641–651.280. McKusick, V.A. The cardiovascular aspects of Marfan’s syndrome: a heritable disorder of connective tissue / V.A. McKusick // Circulation. – 1955. – Vol. 11. –P. 32l–342.281. Meeuwisse, G.W. Diagnostic criteria in coeliac disease / G.W. Meeuwisse// Acta Paediatrica. – 1970. – Vol. 59, Issue 4. – P. 461–464.282. Megiorni, F. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition:practical implications of the HLA molecular typing / F. Megiorni, A. Pizzuti // Journalof biomedical science. – 2012.
– Vol. 19, Issue 1. – P. 88–93.283. MHC class I chain related gene A (MICA) modulates the development ofcoeliac disease in patients with the high risk heterodimer / A. Lopez–Vazquez [et al.] //Gut. – 2002. – Vol. 50 (3). – P. 336–340.284. Mičetić-Turk, D. Epidemiology of coeliac disease / D. Mičetić-Turk // International Coeliac disease Meeting. Proceedings of international Coeliac DiseaseMeeting, September 2007 / editors J. Dolinšek, T. Ornik. Maribor : University Medical Center Maribor, 2007. P. 37–48.285.
Mild clinical phenotype and subtle radiographic findings in an infant withcartilage-hair hypoplasia / G.Ttirkkani-Asal, Y. Alanay, T. Turul-Ozgiir [et al.] //Turky Journal of Pediatrics. – 2009. – Vol. 51. – P. 493–496.286. Milewicz D.M. Genetic disorders of the elastic fiber system / D.M. Milewicz, Z. Urban, C.
Boyd // Matrix Biol. – 2000. – Vol. 19. – P. 471–480.151287. Mitral valve prolaps and the mitral valve prolaps syndrome: a diagnosticclassification and pathogenesis of symptoms / H. Boudoulas, A. Kolibach, P. Baker [etal.] // American Heart Journal. – 1989. – Vol. 118, № 4. – P. 796–818.288. Maki, M.
Coeliac disease / M. Maki, P. Collin // The Lancet. – 1997. –Vol. 349, No. 9067. – P. 1755–1759.289. Mulder, D.J. Letter: HLA-antigens and coeliac disease / D.J. Mulder // TheLancet. 1974. Vol. 2, No. 7882. P. 727.290. Murray, J.A. Celiac disease in patients with an affected member, type 1 diabetes, iron–deficiency, or osteoporosis? / J.A. Murray // Gastroenterology.
– 2005. –Vol. 128 (4). – P. 147.291. Newly identified genetic risk variants for celiac disease related to the immune response / K.A. Hunt [et al.] // Nature genetics. – 2008. – Vol. 40 (4). – P. 395–402.292. Noncoeliac enteropathy: the differential diagnosis of villous atrophy incontemporary clinical practice / K. Pallav [et al.] // Alimentary Pharmacology & Therapeutics. – 2012. – Vol. 35, № 3.
– P. 380–390.293. Nosology and classification of genetic skeletal disorders: 2010 revision //M.L. Warman, V. Cormier-Daire, C. Hall [et al.] // American Journal of Medicine Genetic. – 2011. – Part A. –Vol. 155A. – P. 943–968.294. Oberhuber, G. The histopathology of coeliac disease: time for a standardized report scheme for pathologists / G. Oberhuber, G. Granditsch, H.
Vogelsang // European Journal of Gastroenterology and Hepatology. – 1999. – Vol. 11, Issue 10. –P. 1185–1194.295. Paracellular versus transcellular intestinal permeability to gliadin peptidesin active celiac disease / S. Ménard [et al.] // The American journal of pathology. –2012. – Vol. 180, Issue 2.
– P. 608–615.296. Paulley, J.W. Jejunal mucosa in idiopathic steatorrhoea / J.W. Paulley // TheLancet. – 1959. – Vol. 274, No. 7104. – P. 646–648.152297. Paulley, J.W. Observations on the Aetiology of Idiopathic Steatorrhoea /J.W. Paulley // BMJ. 1954. Vol. 2, Issue 4900. P. 1307.298.
Peptide binding characteristics of the coeliac disease-associated DQ (alpha1*0501, beta1*0201) molecule / Y. Van de Wal [et al.] // Immunogenetics. –1996. – Vol. 44, Issue 4. – P. 246–253.299. Prevalence and clinical picture of celiac disease in Italian down syndromepatients: a multicenter study / M. Bonamico, P. Mariani, H.M. Danesi [et al.] // Journalof Pediatric Gastroenterology and Nutrition. – 2001. – Vol. 33. – P.
139–143.300. Prevalence of celiac disease among children in Finland / M. Maki [et al.] //The New England journal of medicine. 2003. Vol. 348, No. 25. P. 2517–2524.301. Prevalence of celiac disease in at-risk and not-at-risk groups in the UnitedStates: a large multicenter study / A. Fasano, I. Berti, T. Gerarduzzi [et al.] // Archivesof Internal Medicine.
– 2003. – Vol. 163(3). – P. 286–292.302. Prevalence of celiac disease in at-risk and not-at-risk groups in the UnitedStates: a large multicenter study / A. Fasano [et al.] // Archives of internal medicine. 2003. Vol. 163, No. 3.
P. 286–292.303. Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease / M. Abu-Zekry [et al.] // Journal of PediatricGastroenterology and Nutrition. – 2008. – Vol. 47, Issue 2. – P. 136–140.304. Prevalence of celiac disease in Tunisian blood donors / F.
Bdioui [et al.] //Gastroentérologie Clinique et Biologique. – 2006. – Vol. 30, Issue 1. – P. 33–36.305. Prospective study of dietary fiber, whole grain foods, and small intestinalcancer / A. Schatzkin, Y. Park, M.M. Leizmann [et al.] // Gastroenterology. – 2008. –Vol. 135. – P. 1163–1167.306. Psoriasis in a nationwide cohort study of patients with celiac disease /J.F. Ludvigsson, B.
Lindelöf, F. Zingone, C. Ciacci // Journal of Investigative Dermatology. – 2011. – Vol. 131. – P. 2010–2016.307. Pyeritz, R. Connective Tissue and its Hernitable Disorders: Molecular, Genetik and Medical Aspects / R. Pyeritz. – New York, 1993.153308. Pyeritz, R. E.
Small molecule for a large disease / R. E. Pyeritz // TheNew England Journal of Medicine. – 2008. – Vol. 358, Issue 26. – P. 2829–2831.309. Rashtak, S. Review article: coeliac disease, new approaches to therapy /S. Rashtak, J.A. Murray // Alimentary Pharmacology & Therapeutics. – 2012. –Vol. 10. – P. 1365–2036.310. Rawashdeh, M.O. Celiac disease in Arabs / M.O. Rawashdeh, B. Khalil,E. Raweily // Journal of Pediatric Gastroenterology and Nutrition.
– 1996. – Vol. 23,Issue 4. – P. 415–418.311. Replication of celiac disease UK genome-wide association study results ina US population / C.P. Garner, J.A. Murray, Y.C. Ding, Z. [et al.] // Human MolecularGenetics. – 2009. – Vol. 18. – P. 4219–4225.312. Revisiting genome wide association studies (GWAS) in coeliac disease:replication study in Spanish population and expression analysis of candidate genes /L. Plaza-Izurieta, A. Castellanos-Rubio, I. Irastorza [et al.] // Journal of Medical Genetics. – 2011. – Vol. 48. – P. 493–496.313. Riddle, M.S. The incidence and risk of celiac disease in a healthy US adultpopulation / M.S.
Riddle, J.A. Murray, C.K. Porter // American Journal of Gastroenterology. – 2012. – Vol. 107. – P. 1248–1255.314. Roldan, J.F. The connective tissue diseases and the cardiovascular system.Cht 88 / J.F. Roldan, R.A. O’Rourke, W.C. Roberts // Hurst’s The Heart. – 2008. –P. 2033–2052.315. Rotavirus infection frequency and risk of celiac disease autoimmunity inearly childhood: a longitudinal study / L.C. Stene, M.C. Honeyman, E.J. Hoffenberg,[et al.] // American Journal of Gastroenterology. – 2006. – Vol. 101.
– P. 2333–2340.316. Rubio-Tapia, A. Celiac disease / A. Rubio-Tapia, J.A. Murray // CurrentOpinion In Gastroenterology. – 2010. – Vol. 26. – P. 116–122.317. Screening of the adult population in Iran for coeliac disease: comparison forthe tissue-transglutaminase antibody and anti-endomysial antibody tests / M.R. Akbari[et al.] // European Journal of Gastroenterology and Hepatology.
– 2006. – Vol. 18, Issue 11. – P. 1181–1186.154318. Screening of tissue transglutaminase antibody in healthy blood donors forceliac disease screening in the Turkish population / G. Tatar [et al.] // Digestive Diseases and Science. – 2004. – Vol. 49, Issue 9. – P. 1479–1484.319. Senni, K. Magnesium and connective tissue / K.
Senni, A. FoucaultBertaud, G. Godeau // Magnes Res. 2003. – Vol. 16, N 1. – P. 70–74.320. Seroprevalence, correlates, and characteristics of undetected coeliac diseasein England / West J. [et al.] // Gut. 2003. Vol. 52 (7). P. 960–965.321. Shadi, Rashtak.
Celiac Disease in the Elderly / Shadi Rashtak, Joseph A.Murray / Gastroenterology Clinics of North America. – 2009. – Vol. 38(3). – P. 433–446.322. Sollid, L.M. Celiac disease genetics: current concepts and practical applications / L.M. Sollid, B.A. Lie // Clinical Gastroenterology and Hepatology. – 2005. –Vol. 3, Issue 9.
– P. 843–851.323. Sollid, L.M. Molecular basis of celiac disease / L.M. Sollid // Annual review of immunology. – 2000. – Vol. 18. – P. 53–81.324. Structural Basis for Gluten Intolerance in Celiac Sprue / L. Shan [et al.] //Science. – 2002. – Vol. 297, Issue 5590. – P. 2275–2279.325. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes inceliac disease / C.Y. Kim [et al.] // Proceedings of the National Academy of Sciencesof the United States of America. – 2004. – Vol. 101, Issue 12. – P. 4175–4179.326.
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiacdisease patient preferentially recognize gliadin when presented by DQ8 /K.E.A. Lundin [et al.] // Human Immunology. – 1994. – Vol. 41, Issue 4. – P. 285–291.327. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirementof peptide-MHC stability in celiac disease / M. Bodd [et al.] // Gastroenterology. –2012. – Vol. 142 (3). – P. 552–561.155328.
The Canadian celiac health survey / A. Cranney, M. Zarkadas,I.D. Graham [et al.] // Digestive Diseases and Sciences. – 2007. – Vol. 52. – P. 1087–1095.329. The first large population based twin study of coeliac disease / L. Greco,R Romino, I. Coto [et al.] // Gut. – 2002.
– Vol. 50. – P. 624–628.330. The first large population based twin study of coeliac disease / L. Greco [etal.] // Gut. – 2002. – Vol. 50 (5). – P. 624–628.331. The iceberg of celiac disease: what is below the waterline? / J. West [et al.]// Clinical Gastroenterology and Hepatology. – 2007. – Vol. 5, Issue 1. – P. 59–62.332. The molecular genetics of Marfan syndrome and related disorders / P.